Your browser doesn't support javascript.
loading
Severe hypereosinophilic syndrome successfully treated with a monoclonal antibody against interleukin 5 receptor α - benralizumab.
Kosalka-Wegiel, Joanna; Milewski, Mamert; Siwiec, Andzelika; Strach, Magdalena; Ochrem, Bogdan; Korkosz, Mariusz.
Afiliación
  • Kosalka-Wegiel J; Department of Rheumatology and Immunology, Jagiellonian University Medical College, Kraków, Poland.
  • Milewski M; 2nd Department of Internal Medicine, University Hospital, Kraków, Poland.
  • Siwiec A; 2nd Department of Internal Medicine, University Hospital, Kraków, Poland.
  • Strach M; Department of Rheumatology and Immunology, Jagiellonian University Medical College, Kraków, Poland.
  • Ochrem B; 2nd Department of Internal Medicine, University Hospital, Kraków, Poland.
  • Korkosz M; Department of Rheumatology and Immunology, Jagiellonian University Medical College, Kraków, Poland.
Cent Eur J Immunol ; 46(3): 395-397, 2021.
Article en En | MEDLINE | ID: mdl-34764813
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Cent Eur J Immunol Año: 2021 Tipo del documento: Article País de afiliación: Polonia Pais de publicación: Polonia
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Cent Eur J Immunol Año: 2021 Tipo del documento: Article País de afiliación: Polonia Pais de publicación: Polonia